Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 17, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces Modular Real-Time PCR System
Friday, September 12, 2014
Instrument Provides High Resolution, Less Interference Between Channels.

Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

New Eppendorf Advantage™ Offers
Tuesday, September 02, 2014
Users start their research with great sample prep from Eppendorf.

PrimerDesign Launches World’s Most Affordable qPCR Instrument
Wednesday, August 20, 2014
With a price tag of £3,995 GBP ($6,500 USD) and an ultra-simplified user experience, the instrument, in combination with a new easy-to-use genesig kit range, is designed to make the power of qPCR accessible to a vast swathe of new users.

Improve Gene Expression Results with Bio-Rad’s New Rapid Cell Lysis RT-qPCR Kits
Monday, August 18, 2014
The kits allow researchers to obtain reverse transcription quantitative PCR (RT-qPCR) data directly from cultured cells without the need for a separate RNA purification step.

Merck Millipore Introduces Magna™ Nuclear RIP Kits
Tuesday, August 05, 2014
Facilitates isolation and analysis of RNA molecules associated with chromatin.

Analytik Jena Launches New Generation of Thermal Cyclers
Tuesday, August 05, 2014
TAdvanced from Analytik Jena gives excellent heating and cooling rates.

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology
Thursday, July 24, 2014
MuDT™ technology doubles the channel availability of any real-time PCR instrument.

Bio-Rad Introduces SsoAdvanced™ Universal Inhibitor-Tolerant SYBR®Green Supermix
Tuesday, July 15, 2014
New reagent delivers quality qPCR data from samples that are challenging to amplify.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 583
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv